Market Size (2017)
$104.86M
Vertical: HealthcareBase Year: 2017
Market Size (2017)
$104.86M
Projected (2023)
$951.94M
CAGR (2015–2023)
40.7%
Key Players
11+
This report covers CBD Hemp Oil Market with forecasts from 2015 to 2023. 11 key companies are profiled.
The CBD Hemp Oil Market market is projected to grow at a CAGR of 40.7% from 2015 to 2023.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansCBD Hemp Oil Market
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Mn)
Hemp derived CBD oil:Cannabidiol (CBD) hemp oil is made from high-cannabidiol-containing hemp with a low tetrahydrocannabinol (THC) level. The CBD Hemp oil with low levels of THC are non-psychoactive in nature. CBD molecule interacts through the endocannabinoid system. These systems regulate the body’s appetite, immune response hormones, sleep, and mood.
CBD Capsule/Softgel:
CBD capsules are similar in comparison to capsules as they are surrounded by an outer shell, usually gelatin. CBD Soft gelatin capsule are translucent golden shade standard capsule that are filled with hemp oil and sometimes olive oil as filler.
CBD is a cannabinoid found in the cannabis plant. CBD oil acts as a natural pain reliever, have anti-inflammatory properties and could reduce epileptic seizures, etc. From the past few years, the market for CBD hemp oil had been increasing owing to rising legalization of cannabis and growing R&D in the field. Following the same, it is noted that new market players have been emerging in the market owing to the rising demand for CBD oil. All such factors are estimated to drive the market with a double-digit CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2017
Historical Period
2015 – 2016
Forecast Period
2018 – 2023
Primary Interviews
150+
Historical data (2015–2017) and forecast period (2017–2023)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis section of the report identifies significant developments and activities in the global CBD hemp oil market. It provides an overview of key market developments via prominent industry players. The strategies to gain a significant market share in this growing industry vary from mergers to business partnerships to expansions and acquisitions. The established companies are busy acquiring companies and entering into partnerships with other players.
The global CBD hemp oil market is a fragmented market with numerous companies working towards the development of technologies associated with the advanced processing and extraction of hemp oil. Further, patients suffering from numerous neurological conditions such as epilepsy, Alzheimer’s are consuming hemp oil for medical aid.
Top five major players, namely, Charlotte's Web Botanicals, CV Sciences, Medical Marijuana Inc., Elixinol, and Canopy Growth Corporation cumulatively account for nearly 19% of the market share for CBD hemp oil worldwide. Other key players contributing to the market growth include Aurora Cannabis, HempLife Today, and others.
The top five online brands are CW Hemp, PlusCBD Oil, HempMeds (RHSO), Elixinol and CannazALL. Moreover, some brands are much more successful with sales such as CW Hemp, made by Charlotte's Web Botanicals that owns nearly 7% of the market, followed by PlusCBD Oil made by CV Sciences with 5% market share. Further, the subsequent three companies namely Elixinol, HempMeds by Medical Marijuana Inc. and CannazALL by Hemp Life Today are tied at 2% market share. The fragmentation of this market is such that almost 75% of the market share is contributed from startup companies.
Medical Marijuana Inc. is the world’s first legal supplier of Cannabidiol (CBD). The company’s focus is on areas which include the creation of the international CBD pipeline, manufacture legal cannabis consumer products, cannabis drug, and developing new markets for medical cannabis. The company uses an online portal for the distribution of its products across the world. The company claimed that there were USD 65 million in hemp-based CBD sales in 2015 and that they are the current market leader with over USD 800,000 in retail CBD sales per month. Their CBD sales have grown from USD 3.4 million in 2013 and are expected to be USD 9 million in 2016.
Canopy Growth is the first cannabis company in North America to be publicly traded. The company has a reputation for global diversified cannabis company. The company operates a collection of diverse brands and curated strain variety, supports millions of square feet of indoor greenhouse production capacity, and practices partnerships with some of the leading names in the sector.
The companies are relying on different strategic initiatives including mergers, acquisitions, regional expansions, new product developments, and strategic collaborations to strengthen their positions in the market.
Michael Porter’s five forces analysis determines the attractiveness and competitive intensity of the market. This is a useful tool to understand the strength of an organization’s current competitive position.
The five forces are very significant to develop strategy formulation. The potential of these forces varies from industry to industry. On combining these forces, the profitability of industry can be determined because it will help to shape up the prices that can be charged, the costs that can be borne, and the investment needed to compete in the industry. The five industry forces identified are the threat of new entrants, bargaining power of suppliers, bargaining power of buyers, the threat of substitutes, and rivalry among existing competitors.
The components of each of the forces and the degree or impact of each component in the context of the global CBD hemp oil industry have been broken down and analyzed below.Bargaining Power of Suppliers
Bargaining power of suppliers in the CBD hemp oil market is moderate. In the global CBD oil industry, suppliers are raw materials manufacturers and, intermediates. The number of suppliers in the market is less which limits the supply of hemp to product manufacturers for raw material sourcing, thus leaving suppliers with high bargaining power. Switching cost of these suppliers is also medium as the suppliers tend to enter into long-term associations with the manufacturers. One of the key dominant factors includes the introduction of Farm Bill which will encourage the farmers to cultivate more hemp. As Europe and China are the major cultivators of hemp the absence of one dominant supplier and availability of hemp from the black market increase the bargaining power of suppliers. On the other hand, since the production cost & expensive materials are used for manufacturing of CBD hemp oil, only a moderate number of viable raw material substitutes are available, which further boosts the bargaining power of suppliers in the market.
Threat of Substitutes
The threat of substitutes in the global CBD hemp oil market is high. There are a variety of hemp products available in the market containing CBD compound. Other than oil, the CBD hemp products are available in various forms such as a cream, capsule or soft gel, gummies and natural isolates providing the same medical benefits. These products are available as both prescription and over-the-counter medications in the market. Also, the rising awareness about numerous types of hemp products increases the risk of threat of substitutes in the market.
Threat of New Entrants
The threat of new entrants is moderate to high in the CBD hemp oil market. Previously this industry had only thing stopping new comers from entering the market is the approval required by the government as limited licenses are issued by the government. By means of the Farm Bill this issue has been resolved and an increase in the threat from the new entrant is anticipated in the CBD hemp oil market. The market is also characterized by a moderate degree of brand loyalty.
Bargaining Power of Buyers
The bargaining power of buyers is moderate in the CBD hemp oil market. Patients and hospitals are the major buyers for the market. The presence of buyers in the market is high due to the increasing prevalence of chronic conditions, and rising demand for CBD based products for the treatment purpose. In addition, buyers are price sensitive, which moderately affects their bargaining power in the market. There are a smaller number of manufacturers of CBD based products in the world, which also affects the bargaining power of buyers. Additionally, switching cost is moderate for buyers as many alternative treatments are available at an effective cost.
Intensity of Rivalry
The degree of competition in the global CBD hemp oil market is moderate to high. The high degree of product differentiation among existing players increases the intensity of rivalry in the market. CBD oil manufacturing companies are trying to develop less expensive drugs to make treatment more affordable in the developing region. Moreover, demand for CBD oil is many times higher than supply. So, it also decreases the intensity of the rivalry.
Market estimates by geography (2023)
InsightAmericas leads with $951.94M by 2023, while Asia Pacific is projected to grow fastest at a 40.9% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2015 | 2017 | 2023 | CAGR | SHARE |
|---|---|---|---|---|---|
| Americas | $62.10M | $205.63M | $951.94M | 40.7% | 80% |
| Asia Pacific | $6.41M | $21.49M | $99.63M | 40.9% | 8% |
| Europe | $8.68M | $29.23M | $129.74M | 40.2% | 11% |
| Rest of the World | $1.02M | $3.38M | $14.62M | 39.5% | 1% |
| Total | $78.21M | $259.73M | $1.20B | 40.7% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$951.94M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Others | $484.17M | 40.1% | 40% |
| Pain Relief | $416.50M | 41.4% | 35% |
| Neurological Disorders | $182.52M | 40.5% | 15% |
| Sleeping Disorders & Depression | $87.64M | 40.6% | 7% |
| Multiple Sclerosis | $25.12M | 40.1% | 2% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on CBD Hemp Oil Market covering market dynamics, competitive landscape, and strategic outlook.
The CBD Hemp Oil Market market is projected to reach $951.94M by 2023, growing at 40.7% CAGR. The Others segment holds the largest share.
The global CBD hemp oil market is mainly driven by the rising research funding for cannabinoid research,
legalization of CBD in various regions, and the rising occurrence of chronic diseases and related complications. However, the adverse effects associated with cannabis and stringent government policies may slow the growth of the market.
There are many private and government organizations supporting the research and development for cannabinoids for medical purposes. Cannabis has numerous medicinal properties by which it can cure various diseases. According to the National Institute of Drug Abuse, May 2018 publication, in 2017, the National Institute of Health (NIH) supported 330 projects and spent USD 140 million on cannabinoid research and development. During this investment USD 36 million spent on 70 projects to examine the therapeutic properties of cannabinoids and USD 15 million on 26 projects centered on cannabinoid (CBD). Even in 2016, NIH spent USD 21 million studying therapeutic properties of cannabinoids.
Singapore known for the world's most stringent drug laws is also funding research projects on medical treatments containing synthetically-derived compounds of the cannabis plant. In 2017, the government-run National Research Foundation launched a program to research the therapeutic potential of cannabinoids. It is a part of the organization's USD 25 million initiative to promote the biotech industry in the South-East Asian nation. The main aim of the project is to identify genes to create synthetic cannabinoids, so researchers do not need to grow the cannabis plant.
From all the information, it is observed that the escalating research funding for CBD would boost the CBD oil market.
Cannabis and its derivative products are illegal in Asian countries, but the legal landscape is shifting in several countries. Despite the legal and cultural complications, some countries in Asia are potential markets for cannabidiol (CBD) products. For instance, in November 2018, the Public Health Ministry took the initiative to reclassify cannabis and change its status from a completely prohibited item in Thailand. The use of cannabis is illegal in Japan also, but research into cannabinoids is being undertaken with about 40 farmers given licenses to grow a low-THC strain of Cannabis called Tochigi Shiro.
Apart from the well proven medical advantages of Cannabis, they also have harmful effects on health. According to a 2017 study published in the Pharmacy and Therapeutics journal, heavy or long-term use of cannabis has led to addiction, altered brain development, diminished life satisfaction, cognitive impairment, and poor educational outcomes. It is also found that effects were more adverse in individuals who begin using cannabis-based products as adolescents. The current study has also reported that the most commonly reported non-serious adverse events were dizziness, with an occurrence rate of 15.5% among people exposed to cannabinoids. Long-term use of cannabis is also associated with an increased risk of chronic psychosis-related health disorders and chronic bronchitis.
From all the information, it can be concluded that the adverse effects associated with cannabis can strongly impact the growth of the market.
Pricing is one of the important factors for any product to withstand in the market. The pricing is done in such a way that the product is affordable to the customer, and the seller can generate maximum revenue or market share of the total industry. The key companies are increasing or reducing the cost of their CBD hemp oil products across the world, particularly in, developing region like the Asia Pacific and the Middle East region. On the other hand, the minor and medium-size companies are concentrating to cover the local market with its pricing strategy, which creates pressure among the companies to reduce the price of their products. However, due to the increasing use of CBD hemp oil for medical purpose for the treatment of arthritis, anti-inflammatory and many are contributing to driving the market growth.
On June 2018, the US Food and Drug Administration (FDA) approved the use of Cannabis-derived pharmaceutical drug Epidiolex. Epidiolex an oral solution for the treatment of seizure disorders, Lennox–Gastaut syndrome and Dravet syndrome. Also, the approval of 2018 hemp bill in December 2018 will increase the demand for hemp-based products and resulting in decreasing in the price of products.
The global CBD hemp product market is characterized by the presence of many global, regional, and local vendors. The market is highly competitive with all the players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, quality, and reliability. It is decisive for the vendors to provide cost-efficient and high-quality products, to survive and succeed in an intensely competitive and growing market environment.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 105 companies operating in the CBD Hemp Oil Market market, including revenue, employee count, and market positioning where available.
Showing 105 of 105 companies
Charlotte's Web Holdings Inc.
Company Headquarters: Boulder, Colorado US Founded: 2014 Workforce: 500 Company Working: Charlotte's Web Holdings Inc. is involved in the production and distribution of hemp-based, cannabidiol products. There are various products offered by the company which includes tinctures, capsules, and topical. The company distributes its products under Charlotte’s Web and CW names through an e-commerce website, wholesalers, and retailing shops. The company has 3680 retail locations for distributing its products. Earlier the company was known as Stanley Brothers Holdings Inc. and changed its name to Charlotte’s Web in July 2018.
Medical Marijuana Inc
Company Headquarters: California, US Founded: 2009 Workforce: ~50 Company Working: Medical Marijuana Inc. was the world’s first legal supplier of CBD. The company’s focus is on areas such as the development of the international CBD pipeline, the manufacturing of legal cannabis-based consumer products and drugs, and developing new markets for medical cannabis. It offers products such as hemp oils, cannabidiol drops, and tinctures for consumers. It also uses an online portal for the distribution of its products across the world.
Isodiol International Inc.
Company Headquarters: California, US Founded: 2014 Workforce: ~30 Company Working: Isodiol International Inc. is a leader in pharmaceutical grade phytochemical compounds and an industry leader in the manufacturing and development of consumer products. The company has commercialized naturally isolated CBD with micro-encapsulation and nanotechnology to develop quality consumable and topical skincare products. It offers supplements, vitamins, pharmaceuticals, and various nutraceutical products. The company’s product range involves daily products, CBD pet products, CBD sport products, and skin care products.
Canopy Growth Corporation
Company Headquarters: Ontario, Canada Founded: 2013 Workforce: ~2,000 Company Working: Canopy Growth Corporation, a well-known Canadian company, is engaged in the production, distribution, and marketing of a wide range of cannabis and hemp-based products across the globe. The company operates through two business segments, namely, cannabis, hemp, & other consumer products and Canopy Rivers Inc. It offers renowned brands in the global market, including BioSteel, TWD, Tweed, Tokyo Smoke, First & Free, and DOJA. The firm has a strong presence in Canada, the US, Germany, the UK, Australia, Denmark, Peru, and Brazil.
Aurora Cannabis
Company Headquarters: Edmonton, Alberta Founded: 2013 Workforce: 201-500 Company Working: Aurora Cannabis Inc. is a renowned integrated cannabis company with an industry-leading reputation for continuously elevating and setting the global cannabis industry standard.
Bluebird Botanicals LTD
Company Headquarters: Colorado, US Founded: 2012 Workforce: ~175 employees Company Working: Bluebird Botanicals LTD is a major manufacturer of high-quality Hemp Extracts and CBD oil. The company differentiates itself by producing high-quality CBD products. The company also performs extensive and transparent third-party testing.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence